In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

COVID-19 and pulmonary hypertension

ESC Working Groups on Pulmonary Circulation and Right Ventricular Function webinar

31/01/2022 18:00 31/01/2022 19:00 Europe/Paris COVID-19 and pulmonary hypertension

Access event page

ESC Working Groups contact@escardio.org DD/MM/YYYY
Pharmacology and Pharmacotherapy
ESC Working Groups
Echocardiography: Congenital Heart Disease
Risk Factors and Prevention
Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Online
event

Summary

Join Prof. Stephan Rosenkranz, Assoc. Prof. George Giannakoulas & Dr. Pilar Escribano 

Free for everyone

 

Focus on

Needs assessment and expected educational outcome

To provide physicians with evidence-based information on the best care for COVID-19 patients with pulmonary hypertension (PH). Although other webinars have dealt with the impact of COVID-19 on various cardiovascular conditions, no webinar until now has been designed specifically on the impact of COVID-19 PH patients. With mutations threatening another pandemic wave, attendees will receive a summary of new research from papers published on COVID-19 PH patients treated in different parts of Europe and beyond. This information may be even more useful and timely, given that the upcoming 2022 ESC Guidelines on PH will not likely cover this topic extensively: therefore, a gap may be averted.

Learning objectives

  • the prevalence of COVID-19 in PH patients;
  • the experience with COVID-19 in different parts of Europe and beyond;
  •  the outcome of PH patients infected with SARS-CoV2;
  • the management of COVID-19 in PH – special considerations; and
  • the ‘collateral damage’ by the COVID-19 pandemic on PH management.

 



Register now

Faculty

Speakers

placeholder-faces.jpgDoctor Pilar Escribano, FESC
Complutense University of Madrid
Madrid, Spain

placeholder-faces.jpgProfessor Stephan Rosenkranz
Heart Center at the University of Cologne
Cologne, Germany

Host

George_Giannakoulas_2021.jpgAssociate Professor George Giannakoulas
AHEPA University Hospital
Thessaloniki, Greece

 

Session information

This webinar is designed for healthcare professionals with interest in PH and/or Covid-19, general cardiologists, cardiologists in training, and those wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

An application has been made to the EACCME® for CME accreditation of this event.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).